par Saini, Kamal ;Loi, Sherene ;de Azambuja, Evandro ;Metzger-Filho, Otto;Saini, Monika Lamba;Ignatiadis, Michail ;Dancey, Janet J.E.;Piccart-Gebhart, Martine
Référence Cancer treatment reviews, 39, 8, page (935-946)
Publication Publié, 2013-12
Référence Cancer treatment reviews, 39, 8, page (935-946)
Publication Publié, 2013-12
Article révisé par les pairs
Titre: |
|
Auteur: | Saini, Kamal; Loi, Sherene; de Azambuja, Evandro; Metzger-Filho, Otto; Saini, Monika Lamba; Ignatiadis, Michail; Dancey, Janet J.E.; Piccart-Gebhart, Martine |
Informations sur la publication: | Cancer treatment reviews, 39, 8, page (935-946) |
Statut de publication: | Publié, 2013-12 |
Sujet CREF: | Cancérologie |
Imagerie médicale, radiologie, tomographie | |
Mots-clés: | Breast cancer |
Cross-talk | |
Dual inhibition | |
MAPK | |
MTOR | |
Personalized medicine | |
PI3K | |
Ras/Raf/MEK/ERK | |
Targeted therapy | |
MeSH keywords: | Breast Neoplasms -- drug therapy -- enzymology |
Female | |
Humans | |
Individualized Medicine | |
MAP Kinase Signaling System -- drug effects | |
Mitogen-Activated Protein Kinases -- genetics -- metabolism | |
Phosphatidylinositol 3-Kinase -- genetics -- metabolism | |
Proto-Oncogene Proteins c-akt -- genetics -- metabolism | |
TOR Serine-Threonine Kinases -- genetics -- metabolism | |
Note générale: | SCOPUS: re.j |
Langue: | Anglais |
Identificateurs: | urn:issn:0305-7372 |
info:doi/10.1016/j.ctrv.2013.03.009 | |
info:pii/S0305737213000728 | |
info:scp/84883556505 | |
info:pmid/23643661 |